Back
Atara Biotherapeutics Stock Price Chart
America's Final Republican President
Click here to see his 2024 election prediction.
Sell
23
ATRA
Atara Biotherapeutics
Last Price:
0.69
Seasonality Move:
-9.8%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATRA is experiencing slight selling pressure.
Atara Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.7 | Sell |
| 20-day SMA: | 0.72 | Sell |
| 50-day SMA: | 0.72 | Sell |
| 200-day SMA: | 1.08 | Sell |
| 8-day EMA: | 0.7 | Sell |
| 20-day EMA: | 0.71 | Sell |
| 50-day EMA: | 0.72 | Sell |
| 200-day EMA: | 1.24 | Sell |
Atara Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.95 | Sell |
| Chaikin Money Flow: | -173673 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.68 - 0.74) | Sell |
| Bollinger Bands (100): | (0.57 - 0.81) | Sell |
Atara Biotherapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atara Biotherapeutics Stock
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 0.69 while ATRA 8-day simple moving average is 0.70, which is a Sell signal.
- The stock price of ATRA is 0.69 while Atara Biotherapeutics 20-day SMA is 0.72, which makes it a Sell.
- Atara Biotherapeutics 50-day simple moving average is 0.72 while ATRA share price is 0.69, making it a Sell technically.
- ATRA stock price is 0.69 and Atara Biotherapeutics 200-day simple moving average is 1.08, creating a Sell signal.
ATRA Technical Analysis vs Fundamental Analysis
Sell
23
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy or a Sell?
-
Atara Biotherapeutics stock is rated a Sell
The current Atara Biotherapeutics [ATRA] share price is $0.69. The Score for ATRA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Atara Biotherapeutics Stock Info
Market Cap:
82.36M
Price in USD:
0.69
Share Volume:
524.53K
Atara Biotherapeutics 52-Week Range
52-Week High:
3.02
52-Week Low:
0.20
Sell
23
Atara Biotherapeutics (ATRA)
is a Sell
Atara Biotherapeutics Share Price Forecast
-
What is the Atara Biotherapeutics stock price today?
The Atara Biotherapeutics stock price is 0.69 USD today. -
Will ATRA stock go up or go down?
Atara Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Atara Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atara Biotherapeutics is overvalued.
Is Atara Biotherapeutics Stock a Buy?
- Atara Biotherapeutics share price is 0.69 while ATRA 8-day exponential moving average is 0.70, which is a Sell signal.
- The stock price of ATRA is 0.69 while Atara Biotherapeutics 20-day EMA is 0.71, which makes it a Sell.
- Atara Biotherapeutics 50-day exponential moving average is 0.72 while ATRA share price is 0.69, making it a Sell technically.
- ATRA stock price is 0.69 and Atara Biotherapeutics 200-day simple moving average is 1.24, creating a Sell signal.
Fundamental Analysis of Atara Biotherapeutics
Is Atara Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.79 per share, and an increase next year of $0.26 per share.
Technical Analysis of Atara Biotherapeutics
Should I short Atara Biotherapeutics stock?
- ATRA Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Atara Biotherapeutics is a Sell
- Atara Biotherapeutics Relative Strength Index (RSI) is 46.95, which suggest Atara Biotherapeutics is oversold
- The Bollinger Bands (25) for Atara Biotherapeutics is (0.68 - 0.74), which suggest Atara Biotherapeutics is a Sell
- The Bollinger Bands (100) for Atara Biotherapeutics is (0.57 - 0.81), which suggest Atara Biotherapeutics is a Sell
* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.